Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice

被引:307
作者
Brown, M. [1 ,2 ]
Assen, F. P. [2 ]
Leithner, A. [2 ]
Abe, J. [3 ]
Schachner, H. [1 ]
Asfour, G. [1 ]
Bago-Horvath, Z. [1 ]
Stein, J. V. [3 ]
Uhrin, P. [4 ]
Sixt, M. [2 ]
Kerjaschki, D. [1 ]
机构
[1] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria
[2] IST Austria, A-3400 Klosterneuburg, Austria
[3] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland
[4] Med Univ Vienna, Inst Vasc Biol, A-1090 Vienna, Austria
基金
欧洲研究理事会; 奥地利科学基金会;
关键词
BREAST-CANCER; PREMENOPAUSAL WOMEN; DISTANT METASTASES; LYMPHANGIOGENESIS; RADIOTHERAPY; VASCULATURE; IRRADIATION; INVOLVEMENT; INVASION; MAMMARY;
D O I
10.1126/science.aal3662
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
During metastasis, malignant cells escape the primary tumor, intravasate lymphatic vessels, and reach draining sentinel lymph nodes before they colonize distant organs via the blood circulation. Although lymph node metastasis in cancer patients correlates with poor prognosis, evidence is lacking as to whether and how tumor cells enter the bloodstream via lymph nodes. To investigate this question, we delivered carcinoma cells into the lymph nodes of mice by microinfusing the cells into afferent lymphatic vessels. We found that tumor cells rapidly infiltrated the lymph node parenchyma, invaded blood vessels, and seeded lung metastases without involvement of the thoracic duct. These results suggest that the lymph node blood vessels can serve as an exit route for systemic dissemination of cancer cells in experimental mouse models. Whether this form of tumor cell spreading occurs in cancer patients remains to be determined.
引用
收藏
页码:1408 / +
页数:4
相关论文
共 29 条
  • [1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Interaction of tumor cells and lymphatic vessels in cancer progression
    Alitalo, A.
    Detmar, M.
    [J]. ONCOGENE, 2012, 31 (42) : 4499 - 4508
  • [3] The lymphatic vasculature in disease
    Alitalo, Kari
    [J]. NATURE MEDICINE, 2011, 17 (11) : 1371 - 1380
  • [4] Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration
    Braun, Asolina
    Worbs, Tim
    Moschovakis, G. Leandros
    Halle, Stephan
    Hoffmann, Katharina
    Boelter, Jasmin
    Muenk, Anika
    Foerster, Reinhold
    [J]. NATURE IMMUNOLOGY, 2011, 12 (09) : 879 - U8
  • [5] ROLE OF THORACIC DUCT LYMPH IN CANCER DISSEMINATION
    BURN, JI
    MOORE, GE
    WATNE, AL
    [J]. BRITISH JOURNAL OF CANCER, 1962, 16 (04) : 608 - &
  • [6] Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis
    Burton, Jeremy B.
    Priceman, Saul J.
    Sung, James L.
    Brakenhielm, Ebba
    An, Dong Sung
    Pytowski, Bronislaw
    Alitalo, Kari
    Wu, Lily
    [J]. CANCER RESEARCH, 2008, 68 (19) : 7828 - 7837
  • [7] A Perspective on Cancer Cell Metastasis
    Chaffer, Christine L.
    Weinberg, Robert A.
    [J]. SCIENCE, 2011, 331 (6024) : 1559 - 1564
  • [8] Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival
    Chen, ZT
    Varney, ML
    Backora, MW
    Cowan, K
    Solheim, JC
    Talmadge, JE
    Singh, RK
    [J]. CANCER RESEARCH, 2005, 65 (19) : 9004 - 9011
  • [9] Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
    Cheung, Kevin J.
    Gabrielson, Edward
    Werb, Zena
    Ewald, Andrew J.
    [J]. CELL, 2013, 155 (07) : 1639 - 1651
  • [10] Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses
    Das, Suvendu
    Sarrou, Eliana
    Podgrabinska, Simona
    Cassella, Melanie
    Mungamuri, Sathish Kumar
    Feirt, Nikki
    Gordon, Ronald
    Nagi, Chandandeep S.
    Wang, Yarong
    Entenberg, David
    Condeelis, John
    Skobe, Mihaela
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (08) : 1509 - 1528